Insider Transactions Reported by 22 Insiders of Horizon Therapeutics Public Ltd Co

Location
Dublin, Ireland

There are no Buy or Sell transactions made by insiders since 19 Mar 2025

Horizon Therapeutics Public Ltd Co executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paul W. Hoelscher Evp, Cfo $16,369,533 20 Apr 2022
Barry Moze EVP, Chief Admin. Officer $16,097,271 05 Jan 2022
Jeff Kent Officer $9,737,769 11 May 2021
Brian K. Beeler EVP, General Counsel $7,313,288 17 Sep 2021
Miles W. McHugh Sr VP & Princ. Acctg Officer $5,432,978 04 Jan 2022
James Samuel Shannon Director 06 Oct 2023
Michael A. DesJardin EVP, Technical Operations 06 Oct 2023
Andy Pasternak EVP, Chief Strategy Officer 06 Oct 2023
Sean M. Clayton EVP, General Counsel 06 Oct 2023
Pascale Witz Director 06 Oct 2023
Elizabeth H.z. Thompson EVP, Research & Development 06 Oct 2023
Jacopo Leonardi Pres., Global Commercial Ops 01 Jun 2022
Patrick McIlvenny Chief Accounting Officer 06 Oct 2023
Thomas Watkins Director 06 Oct 2023
Timothy P. Walbert Chairman, President and CEO, Director 06 Oct 2023
Susan Mahony Director 06 Oct 2023
William F. Daniel Director 06 Oct 2023
Aaron Cox EVP, Chief Financial Officer 06 Oct 2023
Jeffrey W. Sherman EVP and Chief Medical Officer 06 Oct 2023
Michael G. Grey Director 06 Oct 2023
Gino Santini Director 06 Oct 2023
Jeff Himawan Director 06 Oct 2023

Recent Insider Transactions by Companies or Individuals for Horizon Therapeutics Public Ltd Co

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.